Live tape
Top 8, mentions 7d16,674NVDA6,173 mentions▲ +0.04GOOGL2,248 mentions▲ +0.05SPY1,878 mentions▲ +0.05QQQ1,680 mentions▲ +0.05SPCX1,377 mentions▲ +0.05AMD1,361 mentions▲ +0.08TSLA1,042 mentions▲ +0.05MSFT915 mentions▲ +0.04

Equity · Healthcare

TNXP

NASDAQ

Tonix Pharmaceuticals Holding (TNXP)

12.37 USD +4.48% vs prior close
Tonix Pharmaceuticals Holding Corp. price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.

Track this symbol on TradingView
Market cap
240.4M USD
Revenue, year to Dec 2025
13.1M USD
EPS, diluted, year to Dec 2025
−14.57 USD
Avg volume
92.4K

as of Jul 17, 2026

Have Tonix Pharmaceuticals Holding (TNXP) insiders bought or sold shares recently?

In the 90 days to 11 Nov 2026, Tonix Pharmaceuticals Holding insiders reported 2 open-market purchases and no sales (SEC Form 4).

Form 4, 90 days to 11 Nov 2026, newest reported trade 27 Aug 2026

2buys
0sells
$40Knet bought
0other filings
Have Tonix Pharmaceuticals Holding (TNXP) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
27 Aug 2026LEDERMAN SETHChief Executive OfficerBuy2,00028K USD
20 Aug 2026BAGGER RICHARD HDirectorBuy1,00013K USD
Bought2 open-market purchases3,000$40K

Which funds hold Tonix Pharmaceuticals Holding (TNXP)?

7 of the 45 institutional funds we track reported a Tonix Pharmaceuticals Holding position for the quarter ended 30 Jun 2026 — a combined 43.3M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold Tonix Pharmaceuticals Holding (TNXP)?
FundPositionSharesValueShares q/q
Point72 Asset ManagementAdded1,166,75214.9M USD+830.3%
Millennium ManagementAdded966,93212.3M USD+340.2%
AQR Capital ManagementAdded882,59511.3M USD+447.5%
Citadel AdvisorsTrimmed195,8592.5M USD−58.2%
Balyasny Asset ManagementTrimmed132,5911.7M USD−57.6%
Two Sigma InvestmentsNew position28,812368K USD
Man GroupNew position18,669238K USD

What has been filed or recorded for Tonix Pharmaceuticals Holding (TNXP)?

The filings we hold for Tonix Pharmaceuticals Holding, newest first: 6 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Tonix Pharmaceuticals Holding (TNXP)?
And
14 Oct 2026Fails to deliverShares failed to deliver24,282 shares149K USD notional · 0.142% of shares out
08 Oct 2026Fails to deliverShares failed to deliver2,201 shares17K USD notional · 0.013% of shares out
02 Oct 2026Fails to deliverShares failed to deliver8,285 shares76K USD notional · 0.048% of shares out
01 Oct 2026Fails to deliverShares failed to deliver801 shares8K USD notional · 0.005% of shares out
30 Sep 2026Fails to deliverShares failed to deliver202 shares2K USD notional · 0.001% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −2.89 USDRevenue $17M
30 Sep 2026FinancialsTotal assets242.4M USDat period end
30 Sep 2026FinancialsTotal equity199.5M USDat period end
28 Sep 2026Fails to deliverShares failed to deliver876 shares9K USD notional · 0.005% of shares out
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −2.44 USDRevenue $14M
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −2.93 USDRevenue $7M
31 Dec 2025Annual reportFY 2025 reportedEPS −14.57 USDRevenue $13M
31 Dec 2025FinancialsRevenue13.1M USDfiscal year
31 Dec 2025FinancialsNet income−124.0M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−14.57 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −3.59 USDRevenue $3M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −3.86 USDRevenue $2M
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −2.84 USDRevenue $2M
31 Dec 2024Annual reportFY 2024 reportedEPS −176.60 USDRevenue $10M

What do people ask about Tonix Pharmaceuticals Holding (TNXP)?

From live data
What is Tonix Pharmaceuticals Holding’s market cap?240.4M

Tonix Pharmaceuticals Holding is worth 240.4M USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.

What is Tonix Pharmaceuticals Holding’s revenue?13.1M

Tonix Pharmaceuticals Holding reported revenue of 13.1M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Tonix Pharmaceuticals Holding insiders bought or sold shares recently?2 purchases

In the 90 days to 11 Nov 2026, Tonix Pharmaceuticals Holding insiders reported 2 open-market purchases and no sales (SEC Form 4). See Insiders

Which funds own Tonix Pharmaceuticals Holding?7 of 45

7 of the 45 funds we track reported a Tonix Pharmaceuticals Holding position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Point72 Asset Management, Millennium Management and AQR Capital Management. See Funds

When did Tonix Pharmaceuticals Holding last report earnings?−2.89

Tonix Pharmaceuticals Holding last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −2.89 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  7. SEC EDGARreported earnings figures and scheduled report dates
  8. SEC EDGARValuation computed from SEC EDGAR filings